Ardelyx Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.48

-0.14 (-3.87%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 17 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +1,254.6% upside

Low Target $33.22

Average Target $47.14

High Target $55.45

Current Price $3.48

Current
$3.48

Target
$47.14

$33.22 $47.14 avg $55.45

Scenario Analysis

Bear Case

$33.22

854.6%

Low target

Base Case

$47.14

+1,254.6%

Avg target

Bull Case

$55.45

+1,493.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$8.40

-58.6% from high

52-Week Low

$3.34

+4.2% from low

Target vs 52W High

$47.14

+461.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%